ATE461217T1
(en )
2010-04-15
GLP-1 COMPOUNDS
NO20083002L
(en )
2008-08-14
Method for using CD40 binding compounds
SG145701A1
(en )
2008-09-29
Piperazine derivatives and their use as therapeutic agents
IL180872A0
(en )
2007-07-04
Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv
SG145700A1
(en )
2008-09-29
Pyridyl derivatives and their use as therapeutic agents
SG145695A1
(en )
2008-09-29
Pyridyl derivatives and their use as therapeutic agents
EP1753428A4
(en )
2010-09-15
Kinase inhibitors as therapeutic agents
GB0307918D0
(en )
2003-05-14
Therapeutic use
PT1506781E
(en )
2005-07-29
COMPOSITION FOR VAGINAL TREATMENT
IL181238A0
(en )
2007-07-04
Therapeutic uses of inhibitors of rtp801
HUS2200036I1
(en )
2022-08-28
Use of dihydroimidazolones for the treatment of dogs
IL177483A0
(en )
2006-12-10
Means for transdermal administration of nicotine
GB0416508D0
(en )
2004-08-25
Therapeutic agents
TW200508233A
(en )
2005-03-01
Chk-1 inhibitors
TW200510398A
(en )
2005-03-16
Novel compounds
ZA200801332B
(en )
2009-10-28
Pentacyclic kinase inhibitors
IL178827A0
(en )
2007-03-08
Use of reboxetine for the treatment of pain
GB0207653D0
(en )
2002-05-15
Methods of using lamellar bodies for therapeutic purposes
PL371524A1
(en )
2005-06-27
Combination therapy for the treatment of bacterial infections
TW200631584A
(en )
2006-09-16
A medicament related to mirtazapine for the treatment of hot flush
LT1496918T
(en )
2023-05-25
Use of sodium meta-arsenite for the treatment of tumours
PL1579859T3
(en )
2007-06-29
Use of N-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury
PT1713438E
(en )
2008-10-14
Medicinal soap
UA6623U
(en )
2005-05-16
Method for increasing therapeutic efficacy of clays
PL1732558T3
(en )
2011-03-31
1-[2h-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of pain